Big Pharma Partnering Terms and Agreements 2020-2024

Big Pharma Partnering Terms and Agreements 2020-2024 provides the reader with the following key benefits:

 

• In-depth understanding of Big Pharma deal trends since 2020
• Access to headline, upfront, milestone and royalty data
• Detailed access to actual Big Pharma contracts entered into by leading biopharma companies
• Identify most active Big Pharma dealmakers since 2020
• Insight into terms included in a Big Pharma partnering agreement, with real world examples
• Understand the key deal terms companies have agreed in previous deals           
• Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Executive Summary

 

Chapter 1 – Introduction

 

Chapter 2 – Trends in Big Pharma dealmaking

 

2.1. Introduction

2.2. Big Pharma partnering over the years

2.3. Most active Big Pharma dealmakers

2.4. Big Pharma partnering by deal type

2.5. Big Pharma partnering by therapy area

2.6. Big Pharma partnering by technology type

2.7. Deal terms for Big Pharma partnering

2.7.1 Big Pharma partnering headline values

2.7.2 Big Pharma deal upfront payments

2.7.3 Big Pharma deal milestone payments

2.7.4 Big Pharma royalty rates

 

Chapter 3 – Leading Big Pharma deals

 

3.1. Introduction

3.2. Top Big Pharma deals by value

 

Chapter 4 – Most active Big Pharma dealmakers

 

4.1. Introduction

4.2. Most active Big Pharma dealmakers

4.3. Most active Big Pharma partnering company profiles

Including Pfizer, Sanofi, Abbott, GlaxoSmithKline, Johnson & Johnson and many others

 

Chapter 5 – Big Pharma contracts dealmaking directory

 

5.1. Introduction

5.2. Big Pharma contracts dealmaking directory

 

Chapter 6 – Big Pharma dealmaking by technology type

 

Appendices

 

Appendix 1 – Big Pharma deals by company A-Z

Appendix 2 – Big Pharma deals by stage of development

Appendix 3 – Big Pharma deals by deal type

Appendix 4 – Big Pharma deals by therapy area

Appendix 5 – Deal type definitions

Appendix 6 – Further reading on dealmaking

 

About Biopharma Research Ltd

 

Current Partnering

Current Agreements

Recent report titles from Current Partnering

 

Table of figures

 

Figure 1: Big Pharma partnering since 2020
Figure 2: Active Big Pharma dealmaking activity– 2020-2024
Figure 3: Big Pharma partnering by deal type since 2020
Figure 4: Big Pharma partnering by disease type since 2020
Figure 5: Big Pharma partnering by technology type since 2020
Figure 6: Big Pharma deals with a headline value
Figure 7: Big Pharma deals with an upfront value
Figure 8: Big Pharma deals with a milestone value
Figure 9: Big Pharma deals with a royalty rate value
Figure 10: Top Big Pharma deals by value since 2020
Figure 11: Most active Big Pharma dealmakers 2020-2024

Pricing options

• $3,995: single-user
• $5,995: multi-user
• $7,995: corporate/enterprise license

 

A full explanation of license type definitions can be found here.

 

Our guarantee

 

Price promise

We guarantee our prices are competitive. If you find the same report advertised at a lower price within 7 days of purchase, we will refund the difference.

 

Latest report

If an update is published within 30 days of your purchase, you will receive it absolutely free of charge.

 

Serious Security

We take your data and security seriously. See our privacy policy for details of how we manage your data.

 

Sales Support

If you have any questions about your report, we will do our best to resolve your query. Contact us direct.

 

Total Trust

Current Partnering is part of Biopharma Research Ltd., based in York, United Kingdom. We have been trading successfully online since 2012 and work with some of the most famous brands in the business. We carefully select our partners to ensure that the publications meet expectations of demanding customers.

1ST Biotherapeutics, 2seventy bio, 3B Pharmaceuticals, 3T Biosciences, 4D Molecular Therapeutics, 4D Pharma, 4Living Biotech, 7 Hills Pharma, 23andMe, 111, 908 Devices, A*STAR Agency for Science, Technology and Research, A2 Biotherapeutics, Abbisko Therapeutics, Abbott Laboratories, Abbott Rapid Diagnostics, Abbvie, AbCellera Biologics, Abceutics, AbelZeta Pharma, Abexxa Biologics, Abingworth Life Sciences, Abiomed, ABL Bio, AbSci, AbTherx, Acceleron Pharma, Accent Therapeutics, Accenture, Access to Comprehensive Genomic Profiling Coalition, Acclinate, Accumulus Synergy, Acepodia, AC Immune, Aclaris Therapeutics, Acrivon Therapeutics, Actelion, Actinium Pharmaceuticals, Actylis, Acuitas Therapeutics, AcuraStem, Adagene, Ada Health, Adamas Pharmaceuticals, Adaptate Biotherapeutics, Adaptimmune, Adaptive Biotechnologies, ADC Therapeutics, Adge Pharmaceuticals, Adimab, ADMA Biologics, Adrestia, Advanz Pharma, Advent International, Aerie Pharmaceuticals, AESOP Technology, Aetion, AffaMed Therapeutics, Affinivax, AGC Biologics, Agenus Bio, AgeX Therapeutics, Agios Pharmaceuticals, AgNovos Healthcare, AgomAb Therapeutics, Aignostics, AIM ImmunoTech, Aiolos Bio, AIon Labs, Aitia, Ajinomoto Bio-Pharma Services, Akouos, Akoya Biosciences, Aktis Oncology, Albany Molecular Research, Albireo, Alchemab, Alcon Laboratories, Alcyone Therapeutics, Aldeyra Therapeutics, Alector, Alectos Therapeutics, Alessa Therapeutics, Alexion Pharmaceuticals, Alex Therapeutics, Aliada Therapeutics, Aligos Therapeutics, AlivaMab Discovery Services, AliveCor, Allele Biotechnology and Pharmaceuticals, Allen Institute for Immunology, Allergan, Alliance for Regenerative Medicine, Allorion Therapeutics, Alloy Therapeutics, Almac Group, Almirall, Alnylam Pharmaceuticals, Alphamab Biopharmaceuticals, Alpine Immune Sciences, Alteogen, Altoida, Alveo Technologies, Alvotech, ALX Oncology, Alydia Health, Alzheimer's Drug Discovery Foundation, ALZpath, AM-Pharma, Amalgam Rx, Amathus Therapeutics, Amazon Web Services, Amblyotech, Ambrx, American College of Cardiology, American Society of Gene and Cell Therapy, Amgen, Amicus Therapeutics, Amneal Pharmaceuticals, Amolyt Pharma, Amoy Diagnostics, Amphastar Pharmaceuticals, Amphista Therapeutics, Amplyx Pharmaceuticals, AMRA Medical, Amunix, AnchorDx, Angelini Pharma, Angle, AnHeart Therapeutics, Anima Biotech, ANI Pharmaceuticals, Ankyra Therapeutics, Anokion, Anpac Bio-Medical Science, ANP Technologies, Antengene, Anumana, Apollo Therapeutics, Apotex, Applied DNA Sciences, AprilBio, APRINOIA Therapeutics, Aptevo Therapeutics, Aqemia, Aqilion, Aquestive Therapeutics, Aquinnah Pharmaceuticals, Arabio, Aragen Life Sciences, Arcadia Consumer Healthcare, ArcherDX, Arch Oncology, Arctos Medical, Arcus Biosciences, Arecor, Arena Pharmaceuticals, Ariceum Therapeutics, Aridis Pharmaceuticals, ArisGlobal, Arixa Pharmaceuticals, Arkuda Therapeutics, Arrakis Therapeutics, Arrowhead Pharmaceuticals, Arsenal Biosciences, Artios Pharma, Artisan Bio, Artiva Biotherapeutics, Arvinas, Arzeda, Asahi Kasei, Asan Medical Center, Ascentage Pharma, Ascidian Therapeutics, Asher Biotherapeutics, Asklepios Biopharmaceutical, Aspect Biosystems, Assembly Biosciences, Astellas Institute for Regenerative Medicine, Astellas Pharma, Astellas Pharma US, Astellas Venture Management, Astex Pharmaceuticals, AstraZeneca, Atalanta Therapeutics, Atara Biotherapeutics, Atea Pharmaceuticals, Atnahs Pharma, Atomwise, Atreca, ATUM, AUM Biosciences, Aurinia Pharmaceuticals, Aurobindo Pharma, Auspex Pharmaceuticals, Autigen, Autobahn Therapeutics, Avenzo Therapeutics, AVEO Oncology, Avidity Biosciences, Avista Therapeutics, Avitide, Avricore Health, Avrobio, Axcelead Drug Discovery Partners, Axsome Therapeutics, Azanta, Azitra, Baidu, Baili Biopharmaceutical, Banner Alzheimer's Institute, Base4 Biotechnology, Basilea Pharmaceutica, Bavarian Nordic, Baxter International, Bayer, Bayer CropScience, BC Cancer Agency, Beam Therapeutics, Beckman Coulter, BehaVR, BeiGene, Beijing InnoCare Pharma, Belharra Therapeutics, Bellus Health, BenevolentAI, BE Pharmaceuticals, Berg, Berkeley Lights, Beth Israel Deaconess Medical Center, Bicycle Therapeutics, BigHat Biosciences, Bill and Melinda Gates Foundation, BillionToOne, Bio-Techne, Bio-Thera Solutions, BioAge Labs, BioArctic AB, biOasis Technologies, BioAtla, Biocartis, BioCity Biopharma, BIOCORP, Biocytogen, Biofourmis, Biogen, Biohaven Pharmaceuticals, BioInvent, BioLabs, Biological E, BiologIC Technologies, Biolojic Design, BioMap, BioMark Diagnostics, Biomedical Advanced Research and Development Authority, BioMed X Innovation Center, bioMerieux, BiomX, Biond Biologics, Bioniz Therapeutics, BioNTech, BioPharma Plasma, Bio Products Laboratory, Biora Therapeutics, BioReference Laboratories, Biosplice, Biotest, Biovac, BioVersys, BJ Bioscience, Blackford, Blackford Analysis, Blacksmith Medicines, Blackstone, Bliss Biopharmaceutical, BlueJay Therapeutics, Blueprint Medicines, Boehringer Ingelheim, Boehringer Ingelheim Vetmedica, Bolden Therapeutics, Bolt Biotherapeutics, Bora Pharmaceuticals, Boston Biomedical, BostonGene, Boston Pharmaceuticals, Boundless Bio, BPL Medical Technologies, Brainomix, Brain Research Through Advancing Innovative NeurotechnologiesInitiative, Breast Cancer Canada, BridgeBio Pharma, BridGene Biosciences, Bridgewest Group, Brigham and Women's Hospital, BrightInsight, Bristol-Myers Squibb, Broad Institute, Burning Rock, BWXT Medical, C4 Therapeutics, C4X Discovery, Cadent Therapeutics, Calithera Biosciences, Calypso Biotech, Cambrian Biopharma, CamDiab, CAMP4 Therapeutics, Canadian Blood Services, Canadian Neuromuscular Disease Registry, Capsida Biotherapeutics, Captor Therapeutics, Cara Care, Caraway Therapeutics, CARB-X, Cardiff Oncology, Cardior Pharmaceuticals, Cardiovascular Systems, Care Access Research, Caribou Biosciences, Caris Life Sciences, Carisma Therapeutics, Carl Zeiss, Carmine Therapeutics, Carmot Therapeutics, Carrick Therapeutics, CARsgen, Cartography Biosciences, Cassiopea, Catalent, Catalyst Pharmaceuticals, CCT Research, CDR-Life, Cedar Clinical Research, Cedilla Therapeutics, Celcuity, CelerisTx, Celgene, Cellares, Cellarity, Cell Cure Neurosciences, Cellectis, CELLINK, Cell Mogrify, Celltrion, Cellular Biomedicine, Celmatix, Celsius Therapeutics, Cend Therapeutics, Centers for Disease Control and Prevention, Centre for Commercialization of Regenerative Medicine (CCRM), Century Therapeutics, Cerevance, Cerevel Therapeutics, Cerveau Technologies, Cevec Pharmaceuticals, CG Oncology, Charles River Laboratories, CHARM Therapeutics, Checkmate Pharmaceuticals, ChemoCentryx, Cheplapharm Arzneimittel, Chiesi Farmaceutici, Chiesi Global Rare Diseases, Children's National Hospital, Chinese Academy of Sciences, Chinook Therapeutics, Cholesgen, Chong Kun Dang, CHO Plus, Chronolife, Chugai Pharmaceutical, Cidara Therapeutics, CinCor Pharma, Cinven, Cipla, Citius Pharmaceuticals, City of Hope, Clear Creek Bio, ClearNote Health, Click Therapeutics, Climate Amplified Disease and Epidemics, Clinton Health Access Initiative, Clover Biopharmaceuticals, Clovis Oncology, Coala Life, Coalition for Epidemic Preparedness Innovations, Cobra Biologics, Code Biotherapeutics, Codex DNA, Codexis, Cognizant, CogState, Columbia University, Comera Life Sciences, Compass Therapeutics, Compugen, ConcertAI, Concr, Conduit Pharmaceuticals, Confo Therapeutics, Contineum Therapeutics, CONTINUUS Pharmaceuticals, Copia Scientific, Cornell University, Corvidia Therapeutics, Corza Medical, Cosette Pharmaceuticals, COTA, Covant Therapeutics, COVAX, Covis Pharmaceutical, CSL, CSL Behring, CStone Pharmaceuticals, Cue Biopharma, Cugene, Cullgen, Cumberland Pharmaceuticals, Curadev Pharma, Curadigm, Cure Duchenne, Cure Genetics, Cure Network Dolby Acceleration Partners, CureVac, Curon Biopharmaceutical, Curreio, CymaBay Therapeutics, CytomX Therapeutics, CytoReason, Cytovation, Daiichi Sankyo, Dana-Farber Cancer Institute, Dare Bioscience, DarioHealth, DarwinHealth, Datavant, Datos Health, Dawn Health, Day One Biopharmaceuticals, Debiopharm, deCODE Genetics, Deerfield Management, Degron Therapeutics, Delpharm, Denali Therapeutics, Denovo Biopharma, Department of Defense, Department of Health - Abu Dhabi, Depixus, Dermira, Desma HC, Dewpoint Therapeutics, DexCom, Diabeloop, Diaccurate, Diamond Light Source, DIAN Diagnostics, Diannei Biotechnology, Diatech Pharmacogenetics, Dicerna Pharmaceuticals, DICE Therapeutics, Disability Solutions, Disarm Therapeutics, DJS Antibodies, DNX Biopharmaceuticals, doc.ai, Dogma Therapeutics, Dr. Falk Pharma, Dr. Reddy's Laboratories, Dragonfly Therapeutics, Drawbridge Health, Dren Bio, DRI Capital, DTx Pharma, Duke Clinical Research Institute (DCRI), Dunad Therapeutics, Dyadic International, Dyno Therapeutics, Eccogene, Echosens, Editas Medicine, EditForce, Edwards Lifesciences, eFFECTOR Therapeutics, Egle Therapeutics, Eisai, Eisai Inc, Eko, Elaaj Bio, Elanco, Elegen, Elektrofi, Eleven Biotherapeutics, Eligo Bioscience, Eli Lilly, Elix, Elpiscience, Elsevier, Elsie Biotechnologies, Embark Biotech, Emcure Pharmaceuticals, EMD Serono, Emergence Therapeutics, Emergent BioSolutions, Enable Injections, Enara Bio, Engage Therapeutics, Engitix, Enigma Biomedical, Enleofen Bio, Ensoma, Enterprise Therapeutics, Entos Pharmaceuticals, Envisagenics, Enzymatica, Enzyre, Epilepsy Foundation (EF), Epivax, Eracal Therapeutics, Erasca, Erasmus University Medical Center, ERS Genomics, ErVimmune, EspeRare Foundation, Esperion Therapeutics, ESSA Pharma, Essential Pharmaceuticals, Essen University Hospital, eTheRNA immunotherapies, ETH Zurich, Eunice Kennedy Shriver Institute of Child Health and Human Development, Eureka Therapeutics, Eurofarma, Eurofins Discovery, European Commission, European Molecular Biology Laboratory, European Union, EVA Pharma, Evaxion Biotech, Everest Medicines, Eversana, Evidation Health, Evopoint Biosciences, EVOQ Therapeutics, Evotec, Evox Therapeutics, Evozyne, ExCEEd Orphan, ExCellThera, Exelead, Exelixis, Exicure, Exonate, Exopharm, Exscientia, Eyebiotech, F-Star Therapeutics, Fabric Genomics, FairJourney Biologics, Fate Therapeutics, Fauna Bio, Ferozsons Laboratories, Ferring Pharmaceuticals, Fight Colorectal Cancer, First Wave Bio, Flagship Biosciences, Flagship Pioneering, Flatiron Health, Flowserve, Flywheel, Foghorn Therapeutics, Food and Drug Administration (FDA), Forbius, Forge Therapeutics, FORMA Therapeutics, Formation Bio, Formosa Pharmaceuticals, Forty Seven, Fosun Pharmaceutical, Foundation Medicine, Fox Chase Cancer Center, Fraunhofer Institute for Molecular Ecology (IME), Frazier Healthcare Ventures, Fred Hutchinson Cancer Research Center, Freenome, Fresenius Kabi Pharmaceuticals, Frontage Clinical Services, Frontier Medicines, FUJIFILM Cellular Dynamics, Fujirebio Diagnostics, Fulcrum Therapeutics, Fulgent Pharma, Fundacion Progreso y Salud, Fusion Genomics, Fusion Pharmaceuticals, FutureGen Biopharm, G1 Therapeutics, G42 Healthcare, Gain Therapeutics, Galecto, Gamaleya National Center, GammaDelta Therapeutics, GC Pharma, Gedeon Richter, GE Healthcare, Geisinger Health System, GeneCentric Therapeutics, Genentech, Generate Biomedicines, Geneseeq, Genesis Therapeutics, Genestack, Genetic Leap, Genevant Sciences, GenFleet Therapeutics, Genmab, GenMark Diagnostics, Genocea Biosciences, Genome and Company, Genome Biologics, GentiBio, Genzyme, German Government, Gero, GI Innovation, Gilead Sciences, Gilgamesh Pharmaceuticals, Ginkgo BioWorks, Glenmark Pharmaceuticals, Global Antibiotic Research and Development Partnership, Global Blood Therapeutics, Global Coalition for Adaptive Research, Global Stem Cell Technology, Glooko, GlycoT Therapeutics, GNS Healthcare, Goethe University Frankfurt, GoodRx, Good Therapeutics, Google, GO Therapeutics, Government of Canada, Government of France, Government of Japan, Government of Netherlands, Government of Singapore, Gracell Biotechnologies, Grail, Grand River Aseptic Manufacturing, Graviton Bioscience, Gritstone Bio, Grunenthal, GSK, GSK Consumer Healthcare, Guardant Health, Gubra, Gyroscope Therapeutics, Hackensack Meridian Health, Halix, HALO Precision Diagnostics, Halozyme Therapeutics, HanaVax, Handl Therapeutics, Hanmi Pharmaceutical, Happify Health, Harbour Biomed, Harpoon Therapeutics, Harrow Health, Harvard Medical School, Harvard University, Hasten Biopharmaceutic, HAYA Therapeutics, Headlands Research, Healis Therapeutics, HealthTab, Heartseed, Helsinn Healthcare, HemoShear, Hetero Labs, HiberCell, HIBio, HiFiBio, Highlight Therapeutics, High Line Bio, HighRes Biosolutions, HilleVax, Hillrom, HitGen, HLS Therapeutics, Hoffmann La Roche, Holmusk, Holobiome, Hologic, Honeywell, Hong Kong Science and Technology Parks, Hookipa Pharma, Horizon Therapeutics, HotSpot Therapeutics, Huma, Hummingbird Bioscience, Hurdle, Hutchmed, Huyabio International, Hypera Pharma, I-mab, i2O Therapeutics, Ibex Medical Analytics, Icagen, Icahn School of Medicine at Mount Sinai, Icon, Icosavax, IDEAYA Biosciences, IDT Biologika, IFM Due, IFM Therapeutics, iGenomix, IGM Biosciences, IgniteData, Ikena Oncology, Iktos, Illumina, ImageBiopsy Lab, ImaginAb, Imago Biosciences, IMBdx, Imbio, Imcyse, IMIDomics, Immatics Biotechnologies, Immune-Onc Therapeutics, ImmuNext, Immunocore, ImmunoGen, Immunome, Immunomedics, Immusoft, Immutep, ImmVira, Imugene, IMV, INBRAIN Neuroelectronics, Incyte, INEX Innovate, InflaRx, Inflazome, Inhibrx, Innate Pharma, INNERVIA Bioelectronics, Innodem Neurosciences, Innovate UK, Innovative Medicines Initiative (IMI), Innovent Biologics, Inpixon, Insilico Biotechnology, Insilico Medicine, Insitro, Inspirna, Institute for Research in Immunology and Cancer – Commercialization of Research, Institute for Systems Biology, Institut Gustave Roussy, Institut Kanser Negara, Insud Pharma, Insulet, Intec Pharma, Integral Molecular, Intensity Therapeutics, International Agencies (Bangladesh), International Process Plants, InveniAI, Invenio Imaging, Invenra, Inventia Life Science, Inversago Pharma, Invetx, Invitae, INVO Bioscience, InxMed, IO Biotech, Ionetix, Ionian University, Ionis Pharmaceuticals, Ionova, IONTAS, Iota Biosciences, Iovance Biotherapeutics, Ipsen, IQVIA, IRBM, Ironwood Pharmaceuticals, ISD Immunotech, Isomorphic Labs, iSTAR Medical, Italian Government, iTeos Therapeutics, Iterative Scopes, ITM Isotopen Technologien, Iveric Bio, Jacobio Pharmaceuticals, Janssen Biotech, Janssen Pharmaceuticals, Janssen Pharmaceutica NV, Janssen Research & Development, Janssen Therapeutics, Janux Therapeutics, Japan Government, Javelin Biotech, Jazz Pharmaceuticals, JCR Pharmaceuticals, Jemincare, Jenner Institute, Jiangsu Hansoh Pharmaceutical, Jiangsu Hengrui Pharmaceuticals, Jnana Therapeutics, Johnson & Johnson, Johnson & Johnson Consumer Companies, Johnson & Johnson Innovation, Johnson & Johnson Vision, Jounce Therapeutics, Journey Medical, Jubilant Life Sciences, Junshi Biosciences, Juvise Pharmaceuticals, Kadmon Pharmaceuticals, Kaiku Health, Kaleido Biosciences, KaliVir Immunotherapeutics, Kallyope, Kamada, KaNDy Therapeutics, Karolinska Institute, Karuna Therapeutics, Karyopharm Therapeutics, Kate Therapeutics, KBP BioSciences, Kedalion Therapeutics, Kelonia Therapeutics, Kelun-Biotech Biopharmaceutical, Keymed Biosciences, Kiadis Pharma, Kindeva Drug Delivery, Kineta, Kings College London, Kiniksa Pharmaceuticals, Kit Check, Kite Pharma, Kiyatec, Kneat, Knight Therapeutics, Koneksa Health, Korro Bio, Kronos Bio, KSQ Therapeutics, KTH Royal Institute of Technology, Kumquat Biosciences, Kura Oncology, Kymab, Kymera Therapeutics, Kyorin Pharmaceutical, Kyowa Hakko Kirin, Kyowa Hakko Kirin Pharmaceuticals, Kyowa Hakko Kogyo, Kyttaro, Kyverna Therapeutics, LabCentral, Laboratoires DELBERT, Labor Dr. Merk & Kollegen, Lacerta Therapeutics, Laekna, Landos Biopharma, LaNova Medicines, Launch Therapeutics, Lava Therapeutics, Lead Pharma, Le Bonheur Children's Hospital, Lee Moffitt Cancer Center, Legend Biotech, LegoChem Biosciences, Leiden University, Leidos, Lepu Biopharma, Les Laboratoires Servier, LFB Biotechnologies, LFB Group, LianBio, Lieber Institute, Lifebit Biotech, Life Edit Therapeutics, LifeLabs Medical Laboratory Services, LifeMax Laboratories, LifeMine Therapeutics, Lifera, Life Raft Group, Ligand Pharmaceuticals, Light Chain Bioscience, Lilly Institute for Genetic Medicine, LimmaTech Biologics, Lindy Biosciences, Lineage Cell Therapeutics, Linnaeus Therapeutics, Lipidomics Consulting, LogicBio Therapeutics, Lonza, LOTTE, Loulou Foundation, Loxo Oncology, LTL Pharma, LUCA Science, Lumen Biomedical, Luminostics, LumiraDx, Lumos Pharma, Lundbeck, Lung Cancer Initiative, Lung Cancer Research Foundation, Lupin Pharmaceuticals, Lupus Research Alliance, Lupus Therapeutics, Luxna Biotech, Lycia Therapeutics, Lyell Immunopharma, Lyfebulb, Lyvgen Biopharma, M2Gen, M42, Mablink Bioscience, mAbXience, Macomics, Macrogenics, Mammoth Biosciences, Mapi Pharma, Marengo Therapeutics, Mariana Oncology, Marinus Pharmaceuticals, Mark Foundation for Cancer Research, Massachusetts General Hospital, Massachusetts Institute of Technology, Massachusetts Life Sciences Center, MassBio, Mass General Brigham, Matrix Medical Network, Maverick Therapeutics, Max Foundation, Mayo Clinic, Maze Therapeutics, McGill University, McKesson, McQuade Center for Strategic Research and Development, MD Anderson Cancer Center, Medial EarlySign, Medicago, Medical Research Council, Medicenna Therapeutics, Medicines Development for Global Health, Medicines Patent Pool Foundation, MEDiC Life Sciences, Medidata Solutions, MediLink Therapeutics, MedinCell, MedRhythms, Medtronic, Meharry Medical College, MEI Pharma, MeiraGTx, Memorial Sloan Kettering Cancer Center, Menarini, Menarini Asia-Pacific, Menicon, Merck and Co, Merck Animal Health, Merck KGaA, Merck Sharpe & Dohme, Meridian Bioscience, Mersana Therapeutics, Merus, Mesoblast, Mestag Therapeutics, Metabolon, Metaphore Biotechnologies, Michael J Fox Foundation, Microbiotica, Microsoft, MILA International, MilliporeSigma, Mimetas, Minapharm, MiNA Therapeutics, MindPeak, Mindset Pharma, Ministry of Health (Denmark), Ministry of Health, Labor and Welfare, Minovia Therapeutics, Mirati Therapeutics, miRecule, Mirimus, MiroBio, Miromatrix Medical, Mirum Pharmaceuticals, MITEM PHARMA, Mitokinin, Mitsubishi Tanabe Pharma, Mitsui, MOBILion Systems, Modag, Moderna, ModeX Therapeutics, Molecular Partners, Molecular Templates, Molecular You, MOMA Therapeutics, Momenta Pharmaceuticals, Monte Rosa Therapeutics, MoonLake Immunotherapeutics, Morehouse School of Medicine, Morningside Ventures, Morphic Therapeutic, MorphoSys, MSD, MSN Pharmaceuticals, Multiple Sclerosis Society of Canada, MustGrow Biologics, Mylan Laboratories, MyoKardia, Myovant Sciences, MYR Pharma, Myrtelle, Nabriva Therapeutics, Nanobiotix, Nanoform, NanoVation Therapeutics, Nashville Biosciences, Natera, National Cancer Center, National Cancer Institute, National Comprehensive Cancer Network (NCCN), National Eye Institute, National Health Service, National Heart, Lung and Blood Institute, National Human Genome Research Institute, National Institute for Innovation in Manufacturing Biopharmaceuticals, National Institute of Arthritis and Musculoskeletal Diseases, National Institute of Dental and Craniofacial Research (NIDCR), National Institute of Infectious Diseases, National Institute of Mental Health, National Institute of Neurological Disorders and Stroke, National Institute of Pharmaceutical Education and Research, National Institute on Deafness and Other Communication Disorders, National Institute on Drug Abuse (NIDA), National Institutes of Biomedical Innovation, Health and Nutrition, National Institutes of Health, National Organization for Rare Disorders, National Resilience, NBE Therapeutics, Nectin Therapeutics, Nektar Therapeutics, Neogene Therapeutics, Neogenomics, NeoImmuneTech, Neoleukin Therapeutics, Neomorph, Neotope, NephroDI Therapeutics, Nerio Therapeutics, Nerviano Medical Sciences, Nestle, NETRIS Pharma, NeuBase Therapeutics, Neumora Therapeutics, Neuraxpharm, Neurimmune Therapeutics, Neurocrine Biosciences, NeuroSense Therapeutics, NewAmsterdam Pharma, New Ruipeng Group, Nexelis, NextRNA Therapeutics, NGM Biopharmaceuticals, NiKang Therapeutics, Nimble Therapeutics, Nimbus Therapeutics, Ningbo NewBay Medical Technology, NKGen Biotech, NKMax America, NLS Pharmaceutics, Noema Pharma, Nona Biosciences, Norgine, Noria Therapeutics, Northern Biologics, Northwestern University, Nouscom, Novadiscovery, Novartis, Novartis Institutes for BioMedical Research, Novartis Pharmaceuticals Canada, Novavax, Novocure, Novome Biotechnologies, Novo Nordisk, Noxopharm, Nucleai, Numab, Nurix Therapeutics, NuvoAir, NWO.ai, Nxera Pharma, Nykode Therapeutics, Oak Hill Bio, OARO, Oblique Therapeutics, Ochre Bio, Octagon Research Solutions, Octapharma, Oklahoma Medical Research Foundation, Olatec Therapeutics, Olema Oncology, Omega Therapeutics, Omniose, Onco360, Oncode Institute, OncoImmune, Oncolytics Biotech, OncoSec Medical, Oncoshot, OneOncology, oNKo-innate, OnKure, Ono Pharmaceutical, Ontario Institute for Cancer Research, OpenAI, Optellum, Orano Med, Orchard Therapeutics, Organon, ORIC Pharmaceuticals, Orifarm, OrigiMed, Origimm Biotechnology, Orion, Orionis Biosciences, Orna Therapeutics, Orsini Healthcare Specialty Pharmacy, OrsoBio, Orum Therapeutics, OSE Immunotherapeutics, Otsuka, Otsuka America Pharmaceutical, Ottawa Hospital Research Institute, Ovid Therapeutics, Owkin, Oxford BioTherapeutics, Oxford Nanopore Technologies, P-Chip, Paige, panCELLa, Pantera, Pantherna Therapeutics, PANTHERx Specialty Pharmacy, Paradigm, Parkinsons Disease Foundation, PathAI, Pathos AI, PDS Biotechnology, Pearl Bio, Pennsylvania Biotechnology Center, PeptiDream, Perception Neuroscience, PerkinElmer, Perrigo, Persephone Biosciences, Personal Genome Diagnostics, Personalis, Peter MacCallum Cancer Institute, Pfizer, Pfizer Canada, Phanes Therapeutics, PharmAbcine, Pharmanovia, Pharmaron, Pharmazz, Phenomic AI, Pheno Therapeutics, Philogen, PhoreMost, Phost’in Therapeutics, PicnicHealth, Pieris Pharmaceuticals, Pierre Fabre, Pillar Biosciences, PineTree Therapeutics, Pionyr Immunotherapeutics, Plexium, PMV Pharma, Pneuma Systems, POINT Biopharma, PointClickCare Technologies, Portage Biotech, Poseida Therapeutics, PostEra, PPD, PRA Health Sciences, Praxis Precision Medicines, Precision BioSciences, PrecisionLife, Predicine, Prellis Biologics, Prelude Therapeutics, Premier Inc, Prenosis, Presage Biosciences, Prevail Therapeutics, Prime Medicine, Prime Therapeutics, Principia Biopharma, Priovant Therapeutics, PRISM BioLab, ProBioGen, Procyon Technologies, ProFound Therapeutics, Progentec Diagnostics, Project to Accelerate New Treatments for Tuberculosis, Promega, Prometheus Biosciences, Prometheus Laboratories, ProofPilot, Propella Therapeutics, ProQR Therapeutics, Protagonist Therapeutics, ProteinQure, Proteologix, ProteoNic, Proteros biostructures, Proteus Digital Health, Prothena, ProThera, Protomer Technologies, Provention Bio, ProvideGx, Proxygen, PSMA Therapeutics, Psylo, PTC Therapeutics, Pulmatrix, Pulmonary Fibrosis Foundation (PFF), Puma Biotechnology, Purdue Pharma, Pyxis Oncology, Q32 Bio, QBiotics, QED Therapeutics, QIAGEN, Qpex Biopharma, Quallent Pharmaceuticals, Quanterix, Quebec Heart and Lung Institute, Queens University Belfast, Quell Therapeutics, Qunol, QurAlis, Qurient, Quris-AI, R-Pharm, Rad AI, Radiomedix, Radionetics Oncology, Radius Health, Rain Oncology, Rakuten Medical, Rallybio, Rancho Santa Fe Bio, Ranok Therapeutics, Ratio Therapeutics, RayzeBio, Reata Pharmaceuticals, Recipharm, Recludix Pharma, Recro Pharma, Recursion, RedHill Biopharma, Redwire, Redx Pharma, RefleXion Medical, Regeneron Genetics Center, Regeneron Pharmaceuticals, Regenxbio, Regio Biosciences, Regor Therapeutics, Reify Health, Relay Therapeutics, Remix Therapeutics, ReNeuron, Repare Therapeutics, Replimune, RetinAI Medical, Reverie Labs, reViral, Revitope Oncology, ReviveMed, RevolKa, Revolution Medicines, Revvity, Rgenta Therapeutics, Rheumatology Research Foundation, Ribometrix, Ribon Therapeutics, Ridgeback Biotherapeutics, Rigel Pharmaceuticals, Rigshospitalet, Riparian Pharmaceuticals, Ripple Therapeutics, Roche, Roche Diagnostics, Rockefeller University, Rockwell Medical, Roivant Sciences, Rona Therapeutics, RosVivo Therapeutics, Roswell Biotechnologies, Royalty Pharma, RQ Biotechnology, Rugen Therapeutics, Russian Direct Investment Fund, Rznomics, Saama, SAB Biotherapeutics, SAGA Diagnostics, Sage Therapeutics, Saiba Animal Health, Saladax Biomedical, Salipro Biotech, Samsung Bioepis, Samsung Biologics, Sandoz, Sangamo Therapeutics, Sanguina, Saniona, Sanofi, Sanofi-Pasteur, Sanofi US Services, Sanquin Blood Supply Foundation, San Raffaele Hospital, SanReno Therapeutics, Saphetor, Sarah Cannon Research Institute, Scenic Biotech, Schreiner Group, Schrodinger, SciClone Pharmaceuticals, SciNeuro Pharmaceuticals, Sciwind Biosciences, Scleroderma Research Foundation, Scorpion Therapeutics, Scribe Therapeutics, Scripps Research Institute, Scynexis, Seagen, Seattle Genetics, Second Genome, Seed Therapeutics, Seikagaku, Selecta Biosciences, Sema4, SemaThera, Sengenics, Septerna, Seqster, Sequential Skin, Seranova Bio, SeraNovo, Serina Therapeutics, Sernova, Serotiny, Serum Institute of India, Seven Bridges Genomics, Shanghai Argo Biopharmaceutical, Shanghai KeChow Pharma, Shape Therapeutics, Shasqi, Shattuck Labs, Shenzhen Kangtai Biological Products, Shionogi, Shionogi Pharma, Shockwave Medical, Siemens Healthineers, Sierra Oncology, Sigilon Therapeutics, Silence Therapeutics, Simcere Pharmaceuticals, Simcha Therapeutics, Simtra BioPharma Solutions, Simulations Plus, Singlera Genomics, Singular Genomics Systems, Sionna Therapeutics, Sirion Biotech, SIT Laboratorio Farmaceutico, Sitryx, SK Bioscience, SK Pharmteco, Skyhawk Therapeutics, Sofinnova Partners, Sonnet BioTherapeutics, Sonrai Analytics, Sony, SOPHiA Genetics, Sorrel Medical, Sosei, Sosei Heptares, SOTIO, Spark Therapeutics, Specifica, Spencer Health Solutions, Spero Therapeutics, Spring Bank Pharmaceuticals, SpringWorks Therapeutics, SRI International, STADA Arzneimittel, Standard BioTools, Standigm, Stanford University School of Medicine, Starpharma, Stemline Therapeutics, Stereotaxis, Strados Labs, Strata Oncology, Strateos, Stratos Genomics, Structural Genomics Consortium, Subtle Medical, Sumitomo Dainippon Pharma, Sumitomo Dainippon Pharma Oncology, Sumitomo Mitsui Banking Corporation, Sumitomo Pharmaceuticals, Sumitovant Biopharma, Sunnybrook Research Institute, Sunovion Pharmaceuticals, Sun Pharma Advanced Research Company, Sun Pharmaceutical, Surface Oncology, Surrozen, Susan G. Komen for the Cure, Sutro Biopharma, Suzhou Ribo Life Sciences, Syapse, Symbiosis, Symphogen, Symvivo, Synaffix, Syndesi Therapeutics, Syneos Health, Syngene International, Synlogic, Syntegon, Synthekine, SyntheX, Syros Pharmaceuticals, Sysmex, Sysnav Healthcare, Systems Oncology, Systimmune, Taiho, Takeda Oncology, Takeda Pharmaceutical, Takeda Pharmaceuticals U.S.A, Takeda Ventures, Talem Therapeutics, Tanabe Research Laboratories, Tandem Diabetes Care, Taysha Gene Therapies, TCR2 Therapeutics, Teijin, Telavant, TeleVet, Telix Pharmaceuticals, Temedica, Tempest Therapeutics, Tempus, Ten63 Therapeutics, TeneoBio, TeneoOne, TeneoTwo, TenNor Therapeutics, Tentarix Biotherapeutics, Teon Therapeutics, Terran Biosciences, Terray Therapeutics, TetraScience, Tetra Therapeutics, Teva Pharmaceutical Industries, Teva Pharmaceuticals USA, The International AIDS Vaccine Initiative, Theramex, TheraPanacea, Thermo Fisher Scientific, Thoeris, Thorne HealthTech, THREAD, Tianjin CanSino Biotechnology, Tidal Therapeutics, Tilak Healthcare, TILT Biotherapeutics, Tizona Therapeutics, Tolerance Therapeutics, Tolero Pharmaceuticals, Tornado Therapeutics, Totus Medicines, Touchlight, Transcenta, Transgene, Translate Bio, TransThera, TreeFrog Therapeutics, Treventis, TRexBio, TrialSpark, Triastek, Trillium Therapeutics, TriNetX, Triumvira Immunologics, Trutino Biosciences, TScan Therapeutics, Tubulis, Turbine, Turning Point Therapeutics, Twist Bioscience, Tyris Therapeutics, Ubie, Ubiquigent, UbiVac, UCB, UCL Business, UK Biobank, UK Government, Ultragenyx Pharmaceuticals, Umoja Biopharma, UniQure, UnitedHealth, United Nations Children Fund, Univeristy of Durham, Universal Cells, Universal Display, University College London, University Health Network, University Hospitals Case Medical Center, University of California, San Diego, University of California Berkeley, University of California Los Angeles, University of California San Francisco, University of Chicago, University of Dundee, University of Florida, University of Georgia, University of Helsinki, University of Houston, University of Maryland School of Medicine, University of Michigan, University of Montreal, University of Nebraska, University of North Carolina, University of Oxford, University of Pennsylvania, University of Pittsburgh, University of Pittsburgh Medical Center, University of Quebec, University of Queensland, University of Toronto, University of Tsukuba, University of Tubingen, University of Utah, University of Washington, University of Wollongong, Unlearn, Unnatural Products, Urovant Sciences, US Army Medical Research Institute of Infectious Diseases, US Department of Agriculture, US Department of Justice, US Government, US Oncology Research, Utrecht University, V-Wave, va-Q-tec, Vaccibody, Vaccinex, Valence Discovery, ValenzaBio, Valeo Pharma, ValGenesis, Vall d’Hebron Research Institute, Valneva, Valo Health, Vanderbilt University, VantAI, Variational AI, VaxEquity, Vect-Horus, VectivBio, Vector Institute, Vedere Bio, Veeva Systems, VelosBio, VenatoRx, Ventus Therapeutics, Ventyx Biosciences, Veracyte, Verana Health, Verantos, Verastem, Verge Genomics, VerImmune, Vernalis, Versanis Bio, Vertex Pharmaceuticals, Veru, Vetigenics, Vibalogics, Vidscrip, Vifor Pharma, ViGeneron, Vigil Neuroscience, ViiV Healthcare, Vincera Pharma, Vipergen, VIPUN Medical, Virbac, Vir Biotechnology, Visiox Pharma, Vitaeris, Vivet Therapeutics, Vividion Therapeutics, Vivtex, Viz.ai, Vizient, Volastra Therapeutics, Voluntis, Vor Biopharma, Voyager Therapeutics, Vysioneer, Walk Vascular, Warburg Pincus, WaVe Lifesciences, WAVE Life Sciences, Wellcome Trust, WellDoc, Wellmarker Bio, Werewolf Therapeutics, Wilson Wolf, Wisconsin Health Information Organization, Wren Therapeutics, WuXi Advanced Therapies, WuXi Biologics, Wuxi STA, Wyss Institute, X-chem, Xavier University of Louisiana, XBiotech, Xencor, XERIS Pharmaceuticals, Xilio Therapeutics, XinThera, XNK Therapeutics, XtalPi, Xyphos Biosciences, Y-Biologics, Yale School of Medicine, Yale University, YASKAWA Electric, Yellow Jersey Therapeutics, Yiviva, Ypsomed, Yuhan Corporation, Yumanity Therapeutics, YuYu Pharma, Zealand Pharma, Zedira, Zenas BioPharma, Zenith Epigenetics, Zentalis Pharmaceuticals, Zhejiang Doer Biotechnology, Zion Pharmaceuticals, Zogenix, Zosano Pharma, Zura Bio, Zymeworks

Current Partnering reports provide insight into the trends and terms of partnering deals in the global life sciences sector.

Current Partnering reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.

Current Partnering analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.

Current Partnering reports source deal data from our proprietary deals and alliances database, Current Agreements. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal. In addition, deal records are updated with new data as it becomes available.

The data in the Current Agreements deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.

Current Partnering provides comprehensive coverage of the following partnering or deal types:
• Asset purchase
• Assignment
• Co-development
• Co-market
• Co-promotion
• Collaborative R&D
• Contract service
• CRADA
• Cross-licensing
• Development
• Distribution
• Equity purchase
• Evaluation
• Grant
• Joint venture
• Licensing
• Loan
• Manufacturing
• Marketing
• Option
• Promotion
• Research
• Royalty financing
• Settlement
• Spin out
• Sub license
• Supply
• Termination
• Warrant

Every deal record is fully categorized and includes the following data, where available:
• Industry sector
• Therapy areas
• Technology type
• Deal components
• Financial terms
• Stage of development
• Exclusivity
• Asset type
• Geographic focus
• Excluded geography
• Company press release
• SEC filing data including contract document

All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.

Financial data and contract documents displayed in deal records is obtained from public sources, where disclosed by the parties to the deal.